Bisphosphonates induce breast cancer cell death in vitro

Journal of Bone and Mineral Research

Volumn 15, Issue 11, 2000, Pages 2211-2221

  Fromigue, Olivia ^a   Lagneaux, Laurence ^a   Body, Jean Jacques ^a  

^a JULES BORDET INSTITUTE   (Belgium)

Author keywords

Apoptosis; Bisphosphonates; Bone metastases; Breast cancer; In vitro

Indexed keywords

BISPHOSPHONIC ACID DERIVATIVE; CLODRONIC ACID; IBANDRONIC ACID; PAMIDRONIC ACID; ZOLEDRONIC ACID;

APOPTOSIS; ARTICLE; BREAST CANCER; CALCIFICATION; CANCER CELL; CELL DEATH; CELL PROLIFERATION; CELL STRAIN MCF 7; DRUG EFFECT; GROWTH INHIBITION; HUMAN; HUMAN CELL; IN VITRO STUDY; OSTEOCLAST; OSTEOLYSIS;

AMINO ACID CHLOROMETHYL KETONES; ANNEXINS; ANTINEOPLASTIC AGENTS; APOPTOSIS; BREAST NEOPLASMS; CASPASES; CELL DEATH; CELL NUCLEUS; CLODRONIC ACID; CYSTEINE PROTEINASE INHIBITORS; DIPHOSPHONATES; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; HUMAN; IMIDAZOLES; KINETICS; SUPPORT, NON-U.S. GOV'T; TUMOR CELLS, CULTURED;

EID: 0033783227     PISSN: 08840431     EISSN: None     Source Type: Journal    
DOI: 10.1359/jbmr.2000.15.11.2211     Document Type: Article

References (37)

1. Experimental basis for the use of bisphopshonates in Paget's disease of bone
2. Bisphosphonates in Bone Disease. From the Laboratory to the Patient
3. A dose-finding study of zoledronate in hypercalcemic cancer patients
4. The binding of pyrophosphate and two diphosphonates by hydroxyapatite crystals
5. Long-term controlled trial with diphosphonate in patients with osteolytic bone metastases
6. Double-blind controlled trial of oral clodronate in patients with bone metastases from breast cancer
7. The effects of short term treatment with alendronate on vertebral density and biochemical markers of bone remodeling in early postmenopausal women
8. Current use of bisphosphonates in oncology. International Bone and Cancer Study Group
9. The effect of 3-amino-1-hydroxypropylidene-1, 1-bisphosphonate (ADP) on the resorptive function of osteoclasts of known nuclear number
10. Migration and phenotypic transformation of osteoclast precursors into mature osteoclasts: The effect of a bisphosphonate
11. Inhibition of osteoclast-like cell formation by bisphosphonates in long-term cultures of human bone marrow
12. Bisphosphonates act on rat bone resorption through the mediation of osteoblasts
13. Interaction between effects of parathyroid hormone and bisphosphonate on regulation of osteoclast activity by the osteoclast-like cell line UMR-106
14. A possible mechanism of the specific action of bisphosphonates on osteoclasts: Tiludronate preferentially affects polarized osteoclasts having ruffled borders
15. Bisphosphonates directly inhibit the bone resorption activity of isolated avian osteoclasts in vitro
16. Bisphosphonates promote apoptosis in murine osteoclasts in vitro and in vivo
17. Bisphosphonates act on osteoblastic cells and inhibit osteoclast formation in mouse marrow cultures
18. Bisphosphonates induce osteoblasts to secrete an inhibitor of osteoclast-mediated resorption
19. Reduction in new metastases in breast cancer with adjuvant clodronate treatment
20. Inhibition of osteolytic bone metastasis of breast cancer by combined treatment with the bisphosphonate ibandronate and tissue inhibitor of matrix metalloproteinase-2
21. Local invasion and metastasis
22. Rapid colorimetric assay for cellular growth and survival: Application to proliferation and cytotoxic assays
23. Differential effects of transforming growth factor β2, dexamethasone and 1, 25-dihydroxyvitamin D on human bone marrow stromal cells
24. Morphological and biochemical assays of apoptosis
25. Bisphosphonates induce apoptosis in human myeloma cell lines: A novel anti-tumor activity
26. Zoledronate is a potent inhibitor of myeloma cell growth and secretion of IL-6 and MMP-1 by the tumoral environment
27. Pamidronate and myeloma cell apoptosis: Results of an in vivo study
28. Bisphosphohates inhibit the adhesion of breast cancer cells to bone matrices in vitro
29. Bisphosphonates inhibit prostate and breast carcinoma cell invasion, but not tumor cell migration through a mechanism independent of apoptosis induction
30. Dose-response study of ibandronate in the treatment of cancer-associated hypercalcaemia
31. Substrate specificities of caspase family proteases
32. Alteration of caspase-3 (CPP-32/Yama/apopain) in wild-type MCF-7, breast cancer cells
33. Clodronate and liposome-encapsulated clodronate are metabolized to a toxic ATP analog, adenosine 5'-(beta, gamma-dichloromethylene) triphosphate, by mammalian cells in vitro
34. Characteristics of clodronate-induced apoptosis in osteoclasts and macrophages
35. Heterocycle-containing bisphosphonates cause apoptosis and inhibit bone resorption by preventing protein prenylation: Evidence from structure-activity relationships in J774 macrophages
36. Farnesol and geranylgeraniol prevent activation of caspases by aminobisphosphonates: Biochemical evidence for two distinct pharmacological classes of bisphosphonate drugs
37. Bisphosphonate action. Alendronate localization in rat bone and effects on osteoclast ultrastructure